newsfilter
← Latest News
PR Newswire·

OncoSec Medical Announces Pricing of $42.0 Million Public Offering of Common Stock

OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec"), a late-stage biotechnology company focused on designing, developing and...